Multiple Assemblies exist for SMTL entry 6iag
Crystal structure of human phosphodiesterase 4D2 catalytic domain with inhibitor NPD-637; X-RAY DIFFRACTION 2.00 Å

	SMTL ID 6iag.1 Ligands ZINC ION; MAGNESIUM ION; 1,2-ETHANEDIOL; 1-cycloheptyl-3-{4-methoxy-3-[(2-methoxyphenyl)methoxy]phenyl}-4,4-dimethyl-4,5-dihydro- 1H-pyrazol-5-one Polypeptides cAMP-specific 3',5'-cyclic phosphodiesterase 4D Oligo-state monomer
	SMTL ID 6iag.2 Ligands ZINC ION; MAGNESIUM ION; 1,2-ETHANEDIOL; 4-(2-HYDROXYETHYL)-1-PIPERAZINE ETHANESULFONIC ACID; 1-cycloheptyl-3-{4-methoxy-3-[(2-methoxyphenyl)methoxy]phenyl}-4,4-dimethyl-4,5-dihydro- 1H-pyrazol-5-one Polypeptides cAMP-specific 3',5'-cyclic phosphodiesterase 4D Oligo-state monomer
	SMTL ID 6iag.3 Ligands ZINC ION; MAGNESIUM ION; 1,2-ETHANEDIOL; 4-(2-HYDROXYETHYL)-1-PIPERAZINE ETHANESULFONIC ACID; 1-cycloheptyl-3-{4-methoxy-3-[(2-methoxyphenyl)methoxy]phenyl}-4,4-dimethyl-4,5-dihydro- 1H-pyrazol-5-one Polypeptides cAMP-specific 3',5'-cyclic phosphodiesterase 4D Oligo-state monomer
	SMTL ID 6iag.4 Ligands ZINC ION; MAGNESIUM ION; 1,2-ETHANEDIOL; DI(HYDROXYETHYL)ETHER; 4-(2-HYDROXYETHYL)-1-PIPERAZINE ETHANESULFONIC ACID; 1-cycloheptyl-3-{4-methoxy-3-[(2-methoxyphenyl)methoxy]phenyl}-4,4-dimethyl-4,5-dihydro- 1H-pyrazol-5-one Polypeptides cAMP-specific 3',5'-cyclic phosphodiesterase 4D Oligo-state monomer